LETIAT4 - Key Persons
Its headquarters are in Barcelona and its plant and allergy research laboratory are in Tres Cantos (Madrid). It has subsidiaries in Germany (Ismaning and Witten) and Portugal (Oporto). LETI Pharma operates with exclusive distributors in several countries in Europe, Latin America and Africa.
Research and expertise are critical elements in the strategy of LETI Pharma. Having innovative, patented products is essential for international growth in selected market segments. Therefore, LETI Pharma devotes between 10 and 20 per cent of its revenue to research and product development.
Internationalization is a key element of our strategy. For a specialized company, entry into foreign markets is a requirement in order to grow, and this is facilitated by having its own products developed through research. Thus, for LETI Pharma, internationalization is both a necessity and an opportunity, besides being an important enriching element for its organization.
LETI Pharma maintains a strategy of strong partnerships and lasting relationships with companies in the sector to enhance its penetration in foreign markets and expand its product range. Likewise, it collaborates with universities and research centres for research and development inside and outside Spain.